Table 1 Comparison between patients’ characteristics in relation to log₁₀ UCN2.

Age (years), mean ± SD

68.5 ± 17.5

76 ± 10.1

p = 0.18

Gender: male/female, n (%)

19/7 (73.1%)

17/9 (65.4%)

p = 0.55

BMI (kg/m²), mean ± SD

22.1 ± 5.2

21.6 ± 3.5

p = 0.92

Systolic blood pressure (mmHg), median (IQR)

95 (84–100.3)

111 (92.3–120)

p = 0.02

Diastolic blood pressure (mmHg), median (IQR)

56.5 (52.5–63)

61.5 (57–73.5)

p = 0.04

Heart rate (bpm), mean ± SD

73.0 ± 12.0

70.7 ± 11.8

p = 0.49

Laboratory parameters

WBC (× 10³/µL), median (IQR)

5800 (4650–7050)

5300 (4250–6175)

p = 0.41

Hb (g/dL), median (IQR)

11.75 (10.5–13.63)

11.25 (10.65–13.4)

p = 0.46

BUN (mg/dL), median (IQR)

21.8 (16.95–29)

28.25 (16.25–43.08)

p = 0.39

Creatinine (mg/dL), median (IQR)

1.06 (0.98–1.42)

1.11 (0.98–1.66)

p = 0.69

eGFR (JSN-CKDI, mL/min/1.73 m²), mean ± SD

50.5 ± 18.6

43.1 ± 18.2

p = 0.16

Uric acid (mg/dL), median (IQR)

6.7 (5.85–7.75)

6.7 (5.5–8.9)

p = 0.96

HbA1c (%), median (IQR)

6.15 (5.3–6.75)

6.1 (5.85–6.53)

p = 0.84

Log₁₀ UCN2, median (IQR)

2.85 (2.73–3.31)

2.05 (1.91–2.37)

Log₁₀ BNP, median (IQR)

2.41 (1.98–2.61)

2.46 (2.17–2.63)

p = 0.72

TroponinT (ng/mL), median (IQR)

0.04 (0.02–0.06)

0.04 (0.02–0.09)

p = 0.84

CRP (mg/L), median (IQR)

0.17 (0.11–1.86)

0.25 (0.09–0.84)

p = 0.82

Echocardiography

LVDd (mm), median (IQR)

54 (45.5–64.5)

49.5 (43–57.3)

p = 0.39

LVDs (mm), mean ± SD

45.6 ± 13.8

38.6 ± 15.2

p = 0.09

LAD (mm), mean ± SD

46.5 ± 10.5

46 ± 7.4

p = 0.85

LVEF (%), median (IQR)

30.5 (24–45.5)

41.5 (34.75–64.78)

p = 0.013

E/e' ratio, median (IQR)

17.86 (13.5–29.77)

18.72 (15.18–25.14)

p = 0.80

TRPG (mmHg), median (IQR)

27 (23–36.8)

34 (24–43.85)

p = 0.27

Medication

β blocker, n (%)

21 (80.8%)

17 (65.4%)

p = 0.21

ACEi/ARB, n (%)

19 (73.1%)

15 (57.7%)

p = 0.24

MRA, n (%)

20 (76.9%)

14 (53.8%)

p = 0.08

ARNI, n (%)

0 (0%)

0 (0%)

SGLT2i, n (%)

2 (7.7%)

2 (7.7%)

p = 1.0

Diuretics, n (%)

20 (76.9%)

23 (88.5%)

p = 0.27

Furosemide (mg), median (IQR)

20 (15–40)

20 (10–40)

p = 0.46

Tolvaptan (mg), median (IQR)

0 (0–4.69)

0 (0–7.5)

p = 0.47